- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Lux Research partners with Intertox to offer a comprehensive nanotech EHS service
The debate over the potential environmental, health, and safety (EHS) risks of nanomaterials has grown in intensity over the past year, as environmental groups call for restrictions and stage protests, and government agencies study the issue and consider regulations. With all this discussion, firms active in nanotech need a comprehensive plan to manage nanomaterial EHS risks today, according to a new report from Lux Research entitled "Taking Action on Nanotech Environmental, Health, and Safety Risks."
"There are three aspects of the nanotech EHS issue that firms need to confront," said Lux Research Analyst Michael W. Holman, Ph.D. "First and foremost, they need to manage real risks of their materials to ensure no actual harm comes to people or the environment. Furthermore, to successfully commercialize nanotech innovations, they must understand perceptual risk, which could undermine public or consumer acceptance of their nano-enabled products, regardless of real risks. And of course, they need to understand the emerging regulatory environment."
To assess the state of nanotech EHS issues and help firms develop strategies for coping with the challenges they present, Lux Research spoke with 17 experts from industry, academia, and non-governmental organizations, and 10 officials from agencies with regulatory authority over nano-enabled products. The research team also conducted in-depth discussions with five start-up CEOs and 10 representatives from leading corporations to understand how EHS issues are affecting nanotech commercialization today, and to identify their best practices. Lux Research found that:
The Lux Research analysis concludes that the unique EHS challenge nanotech presents will drive a new product development framework, just as complex manufacturing drove the “Total Quality” movement. “Companies can’t afford to run extensive toxicity tests on each material their scientists consider using, but they also can’t wait until just before product launch to consider EHS concerns,” said Dr. Holman. “Instead, a staged approach to managing EHS issues should match risk-reducing actions to each step in the product development process.”
To help firms tackle nanotech EHS issues, Lux Research also announced that it has partnered with Intertox, a Seattle-based health science consulting and research firm, to offer a new service which will identify and mitigate potential EHS risks from nanomaterials. “Large, complex organizations that use nanomaterials in many areas struggle to stay on top of EHS issues in this rapidly-evolving field,” said Matthew M. Nordan, President of Lux Research. “By combining Lux Research’s deep understanding of nanotech commercialization with Intertox’s long experience in public health and risk assessment, we will help companies gain competitive advantage from nanotech with the confidence that their products and processes are safe, and that they won’t be exposed to liabilities down the road.”
The report provides in-depth analyses of available data and best practices on nanotech real risks, perceptual risks, and regulations, as well as guidance on how to structure product development and other processes in order to commercialize nanotech innovation safely and efficiently. The full report is available immediately to clients of Lux Research’s Nanotechnology Strategies advisory service. In addition, Dr. Holman will be discussing the report findings with Lux Research clients and selected guests on August 1 as a part of the Lux Research Interactive conference call series. For information on how to become a client, contact Lux Research Vice President Rob Burns at (646) 723-0708. For details on Lux Research Interactive, contact Daniel Gruneberg at (212) 644-9534 or email@example.com.
About Lux Research:
Lux Research provides market intelligence and strategic advice on nanotechnology and the physical sciences. We help our clients make better decisions to profit from cutting-edge technologies by tapping into our analysts' unique expertise and unrivaled network. Our clients include top decision makers at large corporations, investment professionals at leading financial institutions, CEOs of the most innovative start-ups, and visionary public policy makers.
For Lux Executive Summit registration and additional event details, please visit www.luxexecutivesummit.com
To get connected and for more information, click here.Contact:
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Preparing for Nano
Searching for a nanotech self-organizing principle May 1st, 2016
Nanotechnology is changing everything from medicine to self-healing buildings: Nanotechnology is so small it's measured in billionths of metres, and it is revolutionising every aspect of our lives April 2nd, 2016
Durnham University's DEEPEN project comes to a close September 26th, 2012
Technical Seminar at ANFoS 2012 August 22nd, 2012
Move over, solar: The next big renewable energy source could be at our feet October 20th, 2016
Nanosciences: Genes on the rack October 21st, 2016
Nanoparticle vaccinates mice against dengue fever October 21st, 2016
Inspiration from the ocean: An interdisciplinary team of researchers at UC Santa Barbara has developed a non-toxic, high-quality surface treatment for organic field-effect transistors October 18th, 2016
Coffee-infused foam removes lead from contaminated water September 21st, 2016
Mathematical nanotoxicoproteomics: Quantitative characterization of effects of multi-walled carbon nanotubes: This research article by Dr. Subhash Basak et al. will be published in Current Computer-Aided Drug Design, Volume 12, 2016 September 2nd, 2016